Investigational breast cancer vaccine plus immune therapy work well in tandem



Category: Oncology & Cancer

Summary: A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Source: Immunology news

Read More

Be the first to comment

Leave a Reply

Your email address will not be published.


*